Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry
- PCPC
- Jul 31, 2019
- 1 min read
The McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.
Comments